Henshaw Capital’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,122
Closed -$504K 360
2020
Q4
$504K Hold
12,122
0.04% 162
2020
Q3
$515K Buy
12,122
+2,149
+22% +$92.7K 0.04% 146
2020
Q2
$432K Hold
9,973
0.04% 159
2020
Q1
$327K Buy
+9,973
New +$371K 0.03% 184
2019
Q4
Sell
-9,996
Closed -$336K 287
2019
Q3
$336K Buy
9,996
+253
+3% +$8.96K 0.03% 190
2019
Q2
$383K Hold
9,743
0.03% 173
2019
Q1
$395K Hold
9,743
0.03% 169
2018
Q4
$316K Buy
+9,743
New +$393K 0.03% 181
2017
Q4
Sell
-7,573
Closed -$370K 284
2017
Q3
$370K Hold
7,573
0.04% 189
2017
Q2
$366K Buy
7,573
+720
+11% +$33.2K 0.04% 197
2017
Q1
$289K Hold
6,853
0.03% 220
2016
Q4
$289K Hold
6,853
0.03% 212
2016
Q3
$300K Buy
+6,853
New +$307K 0.04% 199

Other funds holding FMS

Henshaw Capital's FMS Position: Q1 2021 in Review

Henshaw Capital sold out of Fresenius Medical Care (FMS) in Q1 2021, closing a stake of 12,122 shares — an estimated $504K sold.

Henshaw Capital first reported a position in FMS in Q3 2016 and held it in 13 quarters. The position peaked at $515K in Q3 2020. 167 funds tracked by Wall St. Rank hold FMS as of Q1 2021.

  • Henshaw Capital reported no remaining Fresenius Medical Care position as of Q1 2021 after selling out during the quarter.
  • Henshaw Capital sold 12,122 Fresenius Medical Care shares in Q1 2021, an estimated $504K.
  • Henshaw Capital first reported a position in Fresenius Medical Care in Q3 2016 and held it in 13 quarters.
  • Henshaw Capital's Fresenius Medical Care position peaked at $515K in Q3 2020.
  • 167 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2021.

Based on Henshaw Capital's 13F filing for Q1 2021, filed 28 May 2026.